No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Daratumumab-based therapies were associated with higher rates of sustained minimal residual disease negativity in patients with newly diagnosed multiple myeloma

byKathleen Lau

February 3, 2022

in StudyGraphics

Reading Time: 1 min read

Effectiveness of sacubitril-valsartan in post-myocardial infarction management

RelatedReports

Variation noted across pre- and post-marketing studies for FDA approved devices

Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Chronic Disease

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

February 19, 2026

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

2 Minute Medicine Rewind

January 13, 2026

Shorter overall survival among patients with monoclonal gammopathy of undetermined significance

Chronic Disease

Pre-maintenance positron emission tomography/computed tomography and bone marrow multiparameter flow cytometry are important for prognostication in multiple myeloma treated with daratumumab

January 13, 2026

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial

Psychosocial barriers may hinder expanded buprenorphine access amongst opioid use disorder patients

#VisualAbstract: Skin cancer risk factors and screening differ among Asian American individuals

Novel coronavirus identified from patients with pneumonia in Wuhan, China

2 Minute Medicine Rewind February 7, 2022

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports